This inventor holds 1 USPTO granted patent. Top assignees: Kowa Company Limited, The University of Edinburgh, University of Strathclyde. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 2009
Title: Robert Ramage: Innovator in Pharmaceutical Composition
Introduction
Robert Ramage is a notable inventor based in Lothian, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on peptide derivatives. His research focuses on developing therapeutic agents that address various medical conditions.
Latest Patents
Ramage holds a patent for a "Par-2-activating peptide derivative and pharmaceutical composition using the same." This invention relates to a peptide derivative represented by the general formula (I) or a salt thereof. The formula includes components that are useful as prophylactic and therapeutic agents for a range of conditions, including dysfunction of masticatory, dysphagia, dysgeusia, and several others. His patent is a testament to his commitment to advancing medical science and improving patient care. He has 1 patent to his name.
Career Highlights
Throughout his career, Robert Ramage has worked with prestigious institutions, including the University of Edinburgh and the University of Strathclyde. His academic background and research endeavors have positioned him as a key figure in the pharmaceutical field. His work has not only contributed to scientific knowledge but has also paved the way for new therapeutic options.
Collaborations
Ramage has collaborated with notable colleagues, including Lu Jiang and Pu Wang. These partnerships have enhanced his research and expanded the impact of his inventions in the pharmaceutical industry.
Conclusion
Robert Ramage's innovative work in peptide derivatives and pharmaceutical compositions highlights his dedication to improving health outcomes. His contributions to the field are significant and continue to influence future research and development in pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile